About Healthcare Venture Capital Fund
Healthcare Venture Capital Fund is a co-investment platform built for physician investors and the healthcare venture firms they partner with. We aggregate physician capital into deal-by-deal SPVs that invest side-by-side with leading healthcare VCs at the same terms—same valuation, same preferences, same structure. Pari passu, no double layer of fees.
Why physician investors
Doctors are the most fluent operators in their own sector and the most underserved as venture LPs. Traditional healthcare funds set minimums that exclude individual physicians, bundle healthcare into broader multi-sector mandates that dilute exposure, or wrap everything in feeder structures that compress returns. HVCF was built to fix all three. Each SPV is healthcare-only, structured as a 506(c) offering for accredited investors, and isolated from every other vehicle so performance in one deal cannot offset carry in another.
How we partner with venture firms
We do not source primary deals. We do not negotiate term sheets. We co-invest. Our value to a healthcare VC firm is distribution: a vetted physician investor network, a sector-native intelligence platform, and a real estate sister fund that gives portfolio companies a credible counterparty for clinic buildouts and sale-leasebacks. Partners keep what they already do well. HVCF adds capacity, capital, and clinical credibility on top.
The broader ecosystem
HVCF is one of three connected platforms. Healthcare Discovery (HD.ai) is the intelligence layer—daily research synthesis across precision medicine, AI in healthcare, drug discovery, longevity, and digital health. Healthcare Real Estate Fund is the real-asset layer—NNN-leased medical office and outpatient infrastructure, currently operating as Fund II. Together the three platforms form a single thesis: capital flows where care is delivered, and physicians belong on every side of that flow.
Who we serve
Physician investors seeking direct, healthcare-focused venture exposure with meaningful minimums, transparent structures, and deals they can underwrite using their own clinical judgment. Family offices and accredited investors looking for sector-pure healthcare innovation allocations. And healthcare venture firms looking for a co-investment partner that brings something other than just check size.